Douglas Dynamics slips over 5% after narrowing guidance to reflect 'lowest snowfall season in decades' Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER AFTER EARNINGS
- FB Financial (FBK) up 1.8%
ALSO HIGHER
- Avenue Therapeutics (ATXI) up 13.0% after providing update from Type C meeting with FDA for Tramadol
- Origin Materials (ORGN) up 5.2% after accelerating strategic partnership with SCGP
- Innoviva (INVA) up 2.9% after its sulbactam-durlobactam was recommended for approval by FDA panel
- Gamida Cell (GMDA) up 2.7% after announcing Omisirge therapy receives FDA approval after its sulbactam-durlobactam was recommended for approval by panel
- BWX (BWXT) up 2.3% after announcing that BWX-led team was awarded $45B contract for DOE's Hanford site
DOWN AFTER EARNINGS
- Pinnacle Financial (PNFP) down 0.4%
ALSO LOWER
- Quipt Home Medical (QIPT) down 14.7% after $35M bought deal offering
- Douglas Dynamics (PLOW) down 5.5% after narrowing FY23 EPS lower due to 'lowest snowfall season in decades'
- Enovix Corporation (ENVX) down 5.5% after convertible note offering
Symbols:
FBK ATXI ORGN GMDA - $1.11 /
+0.2919 (+35.68%)
INVA BWXT PNFP QIPT PLOW ENVX Keywords: fly intel, wall street, afterhours, movers, top stories, stocks